Israel Henig

8, Ha'Aliya Street
Haifa, HA 31096, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World Study.

Belumosudil in the Management of Heavily Pretreated Prolonged Chronic GVHD: A Retrospective Multicenter Real-World Study.

Journal: Hematological oncology

Published: March 23, 2026

Intensive induction therapy with FLAG-idarubicinvenetoclax for fit older high-risk patients with acute myeloid leukemia.

Intensive induction therapy with FLAG-idarubicinvenetoclax for fit older high-risk patients with acute myeloid leukemia.

Journal: Haematologica

Published: December 25, 2025

FLAG-IDA-venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world study.

FLAG-IDA-venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world study.

Journal: Haematologica

Published: August 25, 2025

CCR5 predicts neurotoxicity in CAR-T-cell therapy.

CCR5 predicts neurotoxicity in CAR-T-cell therapy.

Journal: British journal of haematology

Published: January 22, 2025

Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.

Impact of discontinuing routine fluoroquinolone prophylaxis in neutropenic allogeneic haematopoietic stem cell transplant recipients: an observational study.

Journal: The Journal of antimicrobial chemotherapy

Published: June 06, 2024

Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approach.

Cardiac safe hematopoietic stem cell transplantation protocol for systemic sclerosis with myocarditis-a two-step approach.

Journal: Rheumatology (Oxford, England)

Published: May 03, 2024

Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.

Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.

Journal: British journal of haematology

Published: March 27, 2024

Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor-T cell therapy.

Cytomegalovirus colitis presenting with lower gastrointestinal bleeding following chimeric antigen receptor-T cell therapy.

Journal: Journal of cellular and molecular medicine

Published: January 29, 2024

Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.

Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.

Journal: Bone marrow transplantation

Published: September 26, 2023

Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?

Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?

Journal: Acta haematologica

Published: July 06, 2023

Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.

Outcomes in progressive systemic sclerosis treated with autologous hematopoietic stem cell transplantation compared with combination therapy.

Journal: Rheumatology (Oxford, England)

Published: July 06, 2023

Complete resolution of gastric antral vascular ectasia after autologous haematopoietic stem cell transplantation in systemic sclerosis.

Complete resolution of gastric antral vascular ectasia after autologous haematopoietic stem cell transplantation in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: February 13, 2023

Showing 1-12 of 45

Last Updated: 09/26/2026